Contact this trialFirst, we need to learn more about you.
Selective Serotonin Reuptake Inhibitor
Escitalopram for Agitation in Alzheimer's Disease
Recruiting2 awardsPhase 3
Washington, District of Columbia
This trial will test whether the antidepressant escitalopram is effective and safe for treating agitation in Alzheimer's dementia.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.